Laboratory of Haematology and Blood Bank Unit, Attikon General Hospital, School of Medicine, University of Athens, Athens, Greece.
Thromb Res. 2010 Feb;125(2):142-6. doi: 10.1016/j.thromres.2009.06.030. Epub 2009 Aug 7.
The most crucial component of all diagnostic criteria for essential thrombocythemia (ET) has been the exclusion of reactive thrombocytosis (RT). Our aim was to evaluate the diagnostic performance of the PFA-100 collagen-epinephrine (CEPI) cartridge test and epinephrine-induced aggregometry individually, but mainly combined, in the differentiation of ET from RT.
26 patients with ET and 25 with RT were studied. Platelet function was analyzed by the PFA-100 and by light transmission aggregometry with epinephrine and ADP. The JAK2 mutational status was identified and hematological parameters, plasma von Willebrand factor antigen and activity levels were also assessed.
The sensitivity (Se), specificity (Sp), positive predictive value (PPV), and the negative predictive value (NPV) of PFA-100 CEPI vs epinephrine-induced aggregometry in the differentiation of ET from RT were estimated as follows: Se (%): 78.9 vs 84.6, Sp (%): 92.0 vs 96.0, PPV (%): 88.2 vs 95.7, NPV (%): 85.2 vs 85.7, respectively. When both of these methods were combined, a lower sensitivity of 68.4%, but a specificity of 100% was attained. The PPV observed with this double abnormal combination was 100% and the NPV 80.6%. Lastly, when we assessed the abnormality for either CEPI CT or epinephrine-induced aggregometry, the sensitivity was 100%, the specificity 88.0%, PPV 86.4% and NPV 100%. Thus, an abnormal combination was strongly suggestive of ET, while normal results with both methods excluded ET.
If our results are replicated by further studies, these two methods could be used very effectively as adjunct markers in the differentiation between ET and RT.
所有特发性血小板增多症(ET)诊断标准中最重要的组成部分一直是排除反应性血小板增多症(RT)。我们的目的是评估 PFA-100 胶原-肾上腺素(CEPI)卡盒试验和肾上腺素诱导聚集试验各自,主要是联合应用,在区分 ET 和 RT 中的诊断性能。
研究了 26 例 ET 患者和 25 例 RT 患者。通过 PFA-100 和用肾上腺素和 ADP 进行的光传输聚集分析来分析血小板功能。鉴定 JAK2 突变状态,并评估血液学参数、血浆血管性血友病因子抗原和活性水平。
PFA-100 CEPI 与肾上腺素诱导聚集试验在区分 ET 和 RT 中的敏感性(Se)、特异性(Sp)、阳性预测值(PPV)和阴性预测值(NPV)估计如下:Se(%):78.9 比 84.6,Sp(%):92.0 比 96.0,PPV(%):88.2 比 95.7,NPV(%):85.2 比 85.7。当这两种方法结合时,敏感性降低至 68.4%,但特异性为 100%。这种双重异常组合的 PPV 为 100%,NPV 为 80.6%。最后,当我们评估 CEPI CT 或肾上腺素诱导聚集试验的异常时,敏感性为 100%,特异性为 88.0%,PPV 为 86.4%,NPV 为 100%。因此,异常组合强烈提示 ET,而两种方法的正常结果则排除 ET。
如果我们的研究结果得到进一步研究的证实,这两种方法可以非常有效地用作区分 ET 和 RT 的辅助标志物。